Contribution	contribution	O	O
of	of	O	O
the	the	O	O
glycine	glycine	S_chemicals	O
site	site	O	O
of	of	O	O
NMDA	nmda	B_chemicals	O
receptors	receptors	I_chemicals	O
in	in	O	O
rostral	rostral	O	O
and	and	O	O
intermediate-caudal	intermediate-caudal	O	O
parts	parts	O	O
of	of	O	O
the	the	O	O
striatum	striatum	O	O
to	to	O	O
the	the	O	O
regulation	regulation	O	O
of	of	O	O
muscle	muscle	O	B_disease
tone	tone	O	I_disease
in	in	O	O
rats	rats	O	O
.	.	O	O

The	the	O	O
aim	aim	O	O
of	of	O	O
the	the	O	O
present	present	O	O
study	study	O	O
was	was	O	O
to	to	O	O
assess	assess	O	O
the	the	O	O
contribution	contribution	O	O
of	of	O	O
the	the	O	O
glycine	glycine	S_chemicals	O
site	site	O	O
of	of	O	O
NMDA	nmda	B_chemicals	O
receptors	receptors	I_chemicals	O
in	in	O	O
the	the	O	O
striatum	striatum	O	O
to	to	O	O
the	the	O	O
regulation	regulation	O	O
of	of	O	O
muscle	muscle	O	B_disease
tone	tone	O	I_disease
.	.	O	O

Muscle	muscle	O	B_disease
tone	tone	O	I_disease
was	was	O	O
examined	examined	O	O
using	using	O	O
a	a	O	O
combined	combined	O	O
mechanoand	mechanoand	O	O
electromyographic	electromyographic	O	O
method	method	O	O
,	,	O	O
which	which	O	O
measured	measured	O	O
simultaneously	simultaneously	O	O
the	the	O	O
muscle	muscle	O	O
resistance	resistance	O	O
(	(	O	O
MMG	mmg	O	O
)	)	O	O
of	of	O	O
the	the	O	O
rat	rat	O	O
's	's	O	O
hind	hind	O	O
foot	foot	O	O
to	to	O	O
passive	passive	O	O
extension	extension	O	O
and	and	O	O
flexion	flexion	O	O
in	in	O	O
the	the	O	O
ankle	ankle	O	O
joint	joint	O	O
and	and	O	O
the	the	O	O
electromyographic	electromyographic	O	O
activity	activity	O	O
(	(	O	O
EMG	emg	O	O
)	)	O	O
of	of	O	O
the	the	O	O
antagonistic	antagonistic	O	O
muscles	muscles	O	O
of	of	O	O
that	that	O	O
joint	joint	O	O
:	:	O	O
gastrocnemius	gastrocnemius	O	O
and	and	O	O
tibialis	tibialis	O	O
anterior	anterior	O	O
.	.	O	O

Muscle	muscle	O	B_disease
rigidity	rigidity	O	I_disease
was	was	O	O
induced	induced	O	O
by	by	O	O
haloperidol	haloperidol	O	O
(	(	O	O
2.5	2.5	O	O
mg/kg	mg/kg	O	O
i.p	i.p	O	O
.	.	O	O
)	)	O	O
.	.	O	O

5,7-dichlorokynurenic	5,7-dichlorokynurenic	O	O
acid	acid	S_chemicals	O
(	(	O	O
5,7-DCKA	5,7-dcka	O	O
)	)	O	O
,	,	O	O
a	a	O	O
selective	selective	O	O
glycine	glycine	S_chemicals	O
site	site	O	O
antagonist	antagonist	O	O
,	,	O	O
injected	injected	O	O
in	in	O	O
doses	doses	O	O
of	of	O	O
2.5	2.5	O	O
and	and	O	O
4.5	4.5	O	O
microg/0.5	microg/0.5	O	O
microl	microl	O	O
bilaterally	bilaterally	O	O
,	,	O	O
into	into	O	O
the	the	O	O
rostral	rostral	O	O
region	region	O	O
of	of	O	O
the	the	O	O
striatum	striatum	O	O
,	,	O	O
decreased	decreased	O	O
both	both	O	O
the	the	O	O
haloperidol-induced	haloperidol-induced	O	O
muscle	muscle	O	B_disease
rigidity	rigidity	O	I_disease
(	(	O	O
MMG	mmg	O	O
)	)	O	O
and	and	O	O
the	the	O	O
enhanced	enhanced	O	O
electromyographic	electromyographic	O	O
activity	activity	O	O
(	(	O	O
EMG	emg	O	O
)	)	O	O
.	.	O	O

5,7-DCKA	5,7-dcka	O	O
injected	injected	O	O
bilaterally	bilaterally	O	O
in	in	O	O
a	a	O	O
dose	dose	O	O
of	of	O	O
4.5	4.5	O	O
microg/0.5	microg/0.5	O	O
microl	microl	O	O
into	into	O	O
the	the	O	O
intermediate-caudal	intermediate-caudal	O	O
region	region	O	O
of	of	O	O
the	the	O	O
striatum	striatum	O	O
of	of	O	O
rats	rats	O	O
not	not	O	O
pretreated	pretreated	O	O
with	with	O	O
haloperidol	haloperidol	O	O
had	had	O	O
no	no	O	O
effect	effect	O	O
on	on	O	O
the	the	O	O
muscle	muscle	O	B_disease
tone	tone	O	I_disease
.	.	O	O

The	the	O	O
present	present	O	O
results	results	O	O
suggest	suggest	O	O
that	that	O	O
blockade	blockade	O	O
of	of	O	O
the	the	O	O
glycine	glycine	S_chemicals	O
site	site	O	O
of	of	O	O
NMDA	nmda	B_chemicals	O
receptors	receptors	I_chemicals	O
in	in	O	O
the	the	O	O
rostral	rostral	O	O
part	part	O	O
of	of	O	O
the	the	O	O
striatum	striatum	O	O
may	may	O	O
be	be	O	O
mainly	mainly	O	O
responsible	responsible	O	O
for	for	O	O
the	the	O	O
antiparkinsonian	antiparkinsonian	S_chemicals	O
action	action	O	O
of	of	O	O
this	this	O	O
drug	drug	S_chemicals	O
.	.	O	O

